2006
DOI: 10.1016/j.jconrel.2006.01.020
|View full text |Cite
|
Sign up to set email alerts
|

Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
34
0
3

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 75 publications
(37 citation statements)
references
References 20 publications
0
34
0
3
Order By: Relevance
“…This suggested that the therapeutic period of Cur was extended after it was presented in the SRSD. Cur suspension upon oral administration resulted in a sharp C max within 0.66 h and the plasma concentration of the drug decreased rapidly, indicating a rapid metabolism of Cur, which was proven by the obtained higher k el and shorter t 1/2 , whereas a relatively slow increase and sustained plasma concentration of Cur for a longer time was observed after the administration of the SRSD, with significantly delayed t max and prolonged K el and K a , suggesting that an obvious sustained release of Cur from the formulation successfully resulted in the sustained absorption of Cur in vivo (7,25,26). Consequently, SRSD persisted for a longer period of time with a higher relative bioavailability of 701.64%.…”
Section: In Vivo Studymentioning
confidence: 93%
“…This suggested that the therapeutic period of Cur was extended after it was presented in the SRSD. Cur suspension upon oral administration resulted in a sharp C max within 0.66 h and the plasma concentration of the drug decreased rapidly, indicating a rapid metabolism of Cur, which was proven by the obtained higher k el and shorter t 1/2 , whereas a relatively slow increase and sustained plasma concentration of Cur for a longer time was observed after the administration of the SRSD, with significantly delayed t max and prolonged K el and K a , suggesting that an obvious sustained release of Cur from the formulation successfully resulted in the sustained absorption of Cur in vivo (7,25,26). Consequently, SRSD persisted for a longer period of time with a higher relative bioavailability of 701.64%.…”
Section: In Vivo Studymentioning
confidence: 93%
“…Many researchers have concluded that an improvement in the release profiles of these drugs by suitable formulation can enhance their bioavailability and reduce side effects (2,3). Class II drugs are considered the best candidates for intervention by formulation, and several methods have been developed to overcome their low aqueous solubility.…”
mentioning
confidence: 99%
“…[8][9][10] Drug release is a crucial and limiting step in oral drug bioavailability 11,12 especially for drugs with low gastrointestinal solubility and high permeability. [13][14][15] Previous studies have shown that the formation of solid dispersions (SDs) is a promising strategy for increasing the dissolution rate and solubility of drugs [16][17][18][19][20] belonging to class II of the Biopharmaceutical Classification System. 21 Dissolution can be improved by reducing the particle size of the drug and increasing the surface area; 22,23 drug wettability can be improved by mixing the drug with a high concentration of the carrier in the surrounding solution; 24,25 and the drug can be transformed from a crystalline to an amorphous state.…”
Section: Introductionmentioning
confidence: 99%